| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 175.657.706 $ | 99,47 | 2.163.786 | ||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 25.331.962 $ | 14,34 | 21.120 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 11.192.966 $ | 6,34 | 44.072 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 10.556.171 $ | 5,98 | 25.398 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 9.370.067 $ | 5,31 | 37.236 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 7.497.847 $ | 4,25 | 58.349 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 5.225.675 $ | 2,96 | 41.362 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 4.714.789 $ | 2,67 | 9.404 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 4.215.748 $ | 2,39 | 8.487 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 3.950.139 $ | 2,24 | 68.555 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 3.557.008 $ | 2,01 | 39.200 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 3.505.549 $ | 1,99 | 8.815 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 3.389.081 $ | 1,92 | 9.359 | |
| Stryker Corp. | Stryker Corp. | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 3.341.397 $ | 1,89 | 10.613 | |
| Elevance Health, Inc. | Elevance Health, Inc. | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 2.859.482 $ | 1,62 | 7.394 | |
| Danaher Corp. | Danaher Corp. | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 2.657.767 $ | 1,50 | 13.953 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 2.645.280 $ | 1,50 | 9.745 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 2.293.959 $ | 1,30 | 15.290 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 1.949.417 $ | 1,10 | 8.206 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 1.809.547 $ | 1,02 | 32.273 | |
| Tenet Healthcare Corp. | Tenet Healthcare Corp. | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 1.761.732 $ | 1,00 | 9.417 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 1.739.822 $ | 0,99 | 16.818 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 1.661.568 $ | 0,94 | 14.490 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.596.114 $ | 0,90 | 13.021 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 1.554.666 $ | 0,88 | 22.200 | |
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 1.552.691 $ | 0,88 | 22.264 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.478.576 $ | 0,84 | 7.895 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 1.340.750 $ | 0,76 | 37.885 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 1.290.215 $ | 0,73 | 4.286 | |
| Viatris, Inc. | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 1.211.644 $ | 0,69 | 76.300 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 1.156.629 $ | 0,65 | 5.100 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.117.035 $ | 0,63 | 1.204 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 1.102.346 $ | 0,62 | 12.186 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 1.088.341 $ | 0,62 | 16.955 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 1.004.723 $ | 0,57 | 11.317 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 949.832 $ | 0,54 | 20.192 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 930.579 $ | 0,53 | 8.728 | |
| Chugai Pharmaceutical Co. Ltd. | Chugai Pharmaceutical Co. Ltd. | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 898.204 $ | 0,51 | 19.400 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 895.056 $ | 0,51 | 8.700 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 864.288 $ | 0,49 | 4.558 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 843.954 $ | 0,48 | 19.774 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 824.123 $ | 0,47 | 1.521 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 820.276 $ | 0,46 | 2.207 | |
| Medtronic plc | Medtronic plc | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 813.592 $ | 0,46 | 10.400 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 741.960 $ | 0,42 | 40.500 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 727.005 $ | 0,41 | 6.210 | |
| Billiontoone, Inc. | Billiontoone, Inc., Class A | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 714.841 $ | 0,40 | 5.958 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 705.403 $ | 0,40 | 2.107 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd., Class H | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 699.274 $ | 0,40 | 32.055 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 687.470 $ | 0,39 | 21.992 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 685.470 $ | 0,39 | 2.570 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 680.383 $ | 0,39 | 28.115 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 670.560 $ | 0,38 | 12.192 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 669.931 $ | 0,38 | 1.265 | |
| Humana, Inc. | Humana, Inc. | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 667.330 $ | 0,38 | 1.680 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 667.056 $ | 0,38 | 6.843 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 663.049 $ | 0,38 | 6.967 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 620.126 $ | 0,35 | 15.917 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 582.308 $ | 0,33 | 2.379 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 577.759 $ | 0,33 | 39.654 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 566.843 $ | 0,32 | 11.824 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 547.516 $ | 0,31 | 6.427 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 547.468 $ | 0,31 | 878 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 544.548 $ | 0,31 | 9.865 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 543.295 $ | 0,31 | 6.852 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 541.543 $ | 0,31 | 7.622 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 532.170 $ | 0,30 | 12.402 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 514.693 $ | 0,29 | 27.509 | |
| Kailera Therapeutics, Inc. | Kailera Therapeutics, Inc. | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 513.453 $ | 0,29 | 23.307 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 509.885 $ | 0,29 | 10.047 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 506.622 $ | 0,29 | 20.883 | |
| Agilent Technologies, Inc. | Agilent Technologies, Inc. | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 504.754 $ | 0,29 | 3.800 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 499.220 $ | 0,28 | 13.341 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 484.627 $ | 0,27 | 14.300 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 483.255 $ | 0,27 | 900 | |
| Waters Corp. | Waters Corp. | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 480.051 $ | 0,27 | 1.280 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 472.211 $ | 0,27 | 4.253 | |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 466.700 $ | 0,26 | 1.300 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 457.491 $ | 0,26 | 5.738 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 452.132 $ | 0,26 | 13.174 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 444.720 $ | 0,25 | 5.971 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 425.437 $ | 0,24 | 11.415 | |
| Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Ltd. | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 423.500 $ | 0,24 | 12.500 | |
| Viridian Therapeutics, Inc. | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 416.448 $ | 0,24 | 22.670 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 413.921 $ | 0,23 | 7.900 | |
| Immunome, Inc. | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 408.967 $ | 0,23 | 19.300 | |
| Alignment Healthcare, Inc. | Alignment Healthcare, Inc. | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 396.579 $ | 0,22 | 16.656 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 380.868 $ | 0,22 | 6.552 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 365.982 $ | 0,21 | 11.527 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 358.529 $ | 0,20 | 8.604 | |
| Palvella Therapeutics, Inc. | Palvella Therapeutics, Inc. | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 347.666 $ | 0,20 | 2.275 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 347.138 $ | 0,20 | 6.468 | |
| Climb Bio, Inc. | Climb Bio, Inc. | EC | 28658R106 | Long | Börsenkurs (Stufe 1) | 334.137 $ | 0,19 | 25.624 | |
| ICON plc | ICON plc | EC | IE0005711209 | Long | Börsenkurs (Stufe 1) | 330.049 $ | 0,19 | 1.900 | |
| Seaport Therapeutics, Inc. | Seaport Therapeutics, Inc. | EC | 81221K108 | Long | Börsenkurs (Stufe 1) | 321.847 $ | 0,18 | 14.818 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 289.388 $ | 0,16 | 9.747 | |
| Sonova Holding AG | Sonova Holding AG (Registered) | EC | CH0012549785 | Long | Modellwert (Stufe 2) | 288.328 $ | 0,16 | 1.214 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 286.183 $ | 0,16 | 26.425 | |
| Celldex Therapeutics, Inc. | Celldex Therapeutics, Inc. | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 275.503 $ | 0,16 | 7.404 | |
| MoonLake Immunotherapeutics | MoonLake Immunotherapeutics, Class A | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 272.853 $ | 0,15 | 14.014 | |
| Cencora, Inc. | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 269.680 $ | 0,15 | 953 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 262.406 $ | 0,15 | 9.325 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 256.965 $ | 0,15 | 1.936 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 254.954 $ | 0,14 | 7.792 | |
| Veeva Systems, Inc. | Veeva Systems, Inc., Class A | EC | 922475108 | Long | Börsenkurs (Stufe 1) | 248.458 $ | 0,14 | 1.400 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 240.404 $ | 0,14 | 6.212 | |
| Biohaven Ltd. | Biohaven Ltd. | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 238.050 $ | 0,13 | 15.998 | |
| Generate Biomedicines, Inc. | Generate Biomedicines, Inc. | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 226.952 $ | 0,13 | 13.453 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 224.277 $ | 0,13 | 1.683 | |
| Encompass Health Corp. | Encompass Health Corp. | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 223.286 $ | 0,13 | 2.209 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 219.968 $ | 0,12 | 22.400 | |
| Belite Bio, Inc. | Belite Bio, Inc. | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 215.579 $ | 0,12 | 1.400 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 208.747 $ | 0,12 | 2.561 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 204.842 $ | 0,12 | 1.807 | |
| Immix Biopharma, Inc. | Immix Biopharma, Inc. | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 203.148 $ | 0,12 | 19.704 | |
| Shattuck Labs, Inc. | Shattuck Labs, Inc. | EC | 82024L103 | Long | Börsenkurs (Stufe 1) | 197.859 $ | 0,11 | 28.510 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 196.668 $ | 0,11 | 10.800 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 195.975 $ | 0,11 | 4.455 | |
| Parabilis Medicines, Inc. | Parabilis Medicines, Inc. | EC | 698955101 | Long | Börsenkurs (Stufe 1) | 195.449 $ | 0,11 | 7.141 | |
| Avalyn Pharma, Inc. | Avalyn Pharma, Inc. | EC | 05348Y105 | Long | Börsenkurs (Stufe 1) | 190.311 $ | 0,11 | 5.781 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 186.100 $ | 0,11 | 2.000 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 184.614 $ | 0,10 | 12.357 | |
| IQVIA Holdings, Inc. | IQVIA Holdings, Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 174.284 $ | 0,10 | 902 | |
| Quest Diagnostics, Inc. | Quest Diagnostics, Inc. | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 169.560 $ | 0,10 | 800 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 167.420 $ | 0,09 | 2.660 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 166.814 $ | 0,09 | 4.824 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 166.088 $ | 0,09 | 5.200 | |
| Aktis Oncology, Inc. | Aktis Oncology, Inc. | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 156.767 $ | 0,09 | 4.864 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 153.301 $ | 0,09 | 2.096 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 148.869 $ | 0,08 | 11.900 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 142.566 $ | 0,08 | 5.543 | |
| Atrium Therapeutics, Inc. | Atrium Therapeutics, Inc. | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 139.880 $ | 0,08 | 10.400 | |
| Avalo Therapeutics, Inc. | Avalo Therapeutics, Inc. | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 135.495 $ | 0,08 | 7.332 | |
| Nanobiotix SA | Nanobiotix SA | EC | FR0011341205 | Long | Modellwert (Stufe 2) | 131.000 $ | 0,07 | 3.569 | |
| Tenax Therapeutics, Inc. | Tenax Therapeutics, Inc. | EC | 88032L605 | Long | Börsenkurs (Stufe 1) | 128.869 $ | 0,07 | 8.857 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 124.575 $ | 0,07 | 59.892 | |
| Hemab Therapeutics Holdings, Inc. | Hemab Therapeutics Holdings, Inc. | EC | 423494103 | Long | Börsenkurs (Stufe 1) | 110.998 $ | 0,06 | 3.022 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 109.187 $ | 0,06 | 18.793 | |
| Alto Neuroscience, Inc. | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 108.199 $ | 0,06 | 4.100 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 105.619 $ | 0,06 | 11.854 | |
| Odyssey Therapeutics, Inc. | Odyssey Therapeutics, Inc. | EC | 67613T104 | Long | Börsenkurs (Stufe 1) | 104.233 $ | 0,06 | 5.571 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 98.627 $ | 0,06 | 4.598 | |
| SpyGlass Pharma, Inc. | SpyGlass Pharma, Inc. | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 93.804 $ | 0,05 | 4.214 | |
| Immatics NV | Immatics NV | EC | NL0015285941 | Long | Börsenkurs (Stufe 1) | 86.105 $ | 0,05 | 8.500 | |
| Inspire Medical Systems, Inc. | Inspire Medical Systems, Inc. | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 84.759 $ | 0,05 | 1.900 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 81.613 $ | 0,05 | 26.242 | |
| Celcuity, Inc. | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 80.557 $ | 0,05 | 770 | |
| Crescent Biopharma, Inc. | Crescent Biopharma, Inc. | EC | KYG2545C1042 | Long | Börsenkurs (Stufe 1) | 79.452 $ | 0,04 | 4.414 | |
| Evommune, Inc. | Evommune, Inc. | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 78.850 $ | 0,04 | 5.933 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 76.656 $ | 0,04 | 18.427 | |
| Procept Biorobotics Corp. | Procept Biorobotics Corp. | EC | 74276L105 | Long | Börsenkurs (Stufe 1) | 75.124 $ | 0,04 | 3.327 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 73.923 $ | 0,04 | 1.992 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 71.017 $ | 0,04 | 4.411 | |
| Eikon Therapeutics, Inc. | Eikon Therapeutics, Inc. | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 66.177 $ | 0,04 | 5.071 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 54.324 $ | 0,03 | 900 | |
| Sensorion SA | Sensorion SA | EC | FR0012596468 | Long | Modellwert (Stufe 2) | 51.630 $ | 0,03 | 190.926 | |
| BioMarin Pharmaceutical, Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 51.498 $ | 0,03 | 900 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 46.846 $ | 0,03 | 6.365 | |
| GE HealthCare Technologies, Inc. | GE HealthCare Technologies, Inc. | EC | 36266G107 | Long | Börsenkurs (Stufe 1) | 44.807 $ | 0,03 | 700 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 43.747 $ | 0,02 | 8.767 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 40.704 $ | 0,02 | 9.600 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 39.978 $ | 0,02 | 1.800 | |
| BridgeBio Oncology Therapeutics, Inc. | BridgeBio Oncology Therapeutics, Inc., Class A | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 37.216 $ | 0,02 | 4.884 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 28.138 $ | 0,02 | 1.579 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 25.574 $ | 0,01 | 3.602 | |
| MapLight Therapeutics, Inc. | MapLight Therapeutics, Inc. | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 22.687 $ | 0,01 | 633 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 18.425 $ | 0,01 | 536 | |
| Gesamt | 175.657.706 $ | 99,47 | 2.163.786 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.